• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Take a listen: Why one life insurer is going big on health incentives

checkpoint inhibitors

oncology ward sign cancer hospital
Payers

Evernorth: Use of ICI therapies to treat cancer is growing

The number of cancer patients using immune checkpoint inhibitor drugs has steadily risen since they hit the market in 2011.
Paige Minemyer Aug 14, 2023 4:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings